Comparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol-Associated Hepatitis: A Global Cohort Study
- PMID: 39967231
- PMCID: PMC11950807
- DOI: 10.1111/apt.70024
Comparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol-Associated Hepatitis: A Global Cohort Study
Abstract
Several dynamic models predict mortality and corticosteroid response in alcohol-associated hepatitis (AH), yet no consensus exists on the most effective model. This study aimed to assess predictive models for corticosteroid response and short-term mortality in severe AH within a global cohort. We conducted a multi-national study of patients with severe AH treated with corticosteroids for at least 7 days, enrolled between 2009 and 2019. Dynamic models-Lille-4, Lille-7, trajectory of serum bilirubin (TSB), and neutrophil-to-lymphocyte ratio (NLR)-were used to estimate 30- and 90-day mortality. Lille-7 demonstrated the highest accuracy for both 30- and 90-day mortality.
Keywords: alcohol; alcoholic cirrhosis; alcohol‐associated liver disease; alcohol‐related hepatitis; cirrhosis; end‐stage liver disease; outcome prediction.
© 2025 The Author(s). Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.
Conflict of interest statement
R.B.: consulting for GSK, Novo Nordisk and Boehringer‐Ingelheim. J.G.A.: consulting for 89bio, Agomab, Novo Nordisk, Boehringer Ingelheim, AstraZeneca, Terumo, Boston Pharmaceuticals. Grant support: Salix, Gilead, Cook. L.S.: Consulting for Abbvie, Gilead, Astellas, Worwag, ProMed. D.J.H.: Lecturing for Abbvie, Gilead, Astellas, ProMed.
Figures

References
-
- Arab J. P., Roblero J. P., Altamirano J., et al., “Alcohol‐Related Liver Disease: Clinical Practice Guidelines by the Latin American Association for the Study of the Liver (ALEH),” Annals of Hepatology 18, no. 3 (2019): 518–535. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical